Citations

Clear

65 citation(s) found for "Fox, Michael".

TDP-43–Associated Neurodegenerative Disease Conceptualization and Integrated Staging
Benatar, Michael, Lagier‐Tourenne, Clotilde , Gregory, Jenna, Al-Chalabi, Ammar, Boeve, Bradley F., Maragakis, Nicholas J., Wuu, Joanne, Zeier, Zane, Onyike, Chiadi, Lewcock, Joe, Hovinga, Collin, Jafar-nejad, Paymaan, Uspenskaya, Olga, Simmons, Adam, Browne, Susan E., Rohrer, Jonathan, Petrucelli, Leonard, Shapiro, Jacquelyn, Scharper, Deb, Boxer, Adam, Staffaroni, Adam M. , Dacks, Penny, Dave, Kuldip D. , Majo, Martina de, Mitic, Laura, Fradette, Stephanie , Haeberlein, Samantha Budd , Simuni, Tanya, Dunn, Billy, Lee, Edward B., Js, Gregory , Benatar, Michael, Barmada, Sami, Jicha, Gregory A. , Al‐Chalabi, Ammar , Boeve, Bradley F. , Jack, Clifford R. , Seeley, William W. , Maragakis, Nicholas J. , Wuu, Joanne , Zeier, Zane R. , Hovinga, Collin A. , Jafar‐Nejad, Paymaan , Uspenskaya, Olga, Simmons, Adam, Browne, Susan E. , Petrucelli, L, Ostrow, Lyle W. , Dacks, Penny A. , Turner, Martin R. , Majo, Martina de , Simuni, Tanya , McMillan, Corey T. , Lee, Edward B.

Mayo Clinic

JAMA Neurology | August 24, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1001/jamaneurol.2026.2812 | PMID 42636000 Get It

Importance Classifying disease based on underlying pathobiology rather than clinical phenotype has implications for the development of biomarkers and therapy development. Observations Transactive response DNA-binding protein 43 kDa (TDP-43) pathology is observed across a range of clinically defined neurodegenerative disorders including limbic predominant age-related encephalopathy (LATE), most cases of amyotrophic lateral sclerosis (ALS), inclusion body myositis, multisystem proteinopathy, and approximately half the cases of frontotemporal dementia (FTD). Despite this shared biology, the current nosology for these neurodegenerative disorders is based on their distinct clinical phenotypes. An alternative approach recognizes the central role of TDP-43 pathology in disease pathogenesis, reserving the use of clinical terms like ALS, FTD, or LATE to describe phenotypic manifestations of underlying pathobiology. This approach also recognizes the converging biomarker and neuropathological data indicating that pathology begins presymptomatically, before the overt clinical manifestations of disease appear. Conclusions and Relevance In proposing a pathobiological definition of disease, the goal is to provide a road map for developing biomarkers that accurately reflect the underlying pathobiology of disease and for advancing therapeutic candidates that effectively target fundamental disease mechanisms.
Activation of the endocytosis pathway stratifies subtypes and therapeutic sensitivity in colorectal cancer
Arai, Hiroyuki , Elliott, Andrew , Yang, Yan , Farrell, Alex, Millstein, Joshua , Ou, Fang‐Shu , Innocenti, Federico, Wang, Jingyuan , Jayachandran, Priya , Algaze, Sandra, Soni, Shivani, 张武, Scott, Aaron J. , Hwang, Jimmy J., Weinberg, Benjamin A., Marshall, John, Xiu, Joanne, Korn, W. Michael, Venook, Alan P., Lenz, Heinz‐Josef , Lenz, Heinz-Josef , Arai, Hiroyuki , Elliott, Andrew , Yang, Yan , Millstein, Joshua , Ou, Fang-Shu , Wang, Jingyuan , Jayachandran, Priya , Goldberg, Richard M , Lou, Emil , Goel, Sanjay , Innocenti, Federico , Battaglin, Francesca , Algaze, Sandra , Goldberg, Richard M. , Hall, Michael J. , Lou, Emil , Weinberg, Benjamin A. , Marshall, John L , Goel, Sanjay , Joanne, Xiu, Korn, Wolfgang Michael , Venook, Alan P.

Mayo Clinic

No container title available | July 5, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-10164107/v1 | PMID 42427862 Get It

Abstract Endocytosis regulates receptor trafficking and signaling, yet its role in colorectal cancer (CRC) remains unclear. We analyzed transcriptomic data from 15,025 CRC tumors to evaluate gene expression in clathrin-mediated endocytosis (CME) and the endosomal sorting complexes required for transport (ESCRT) pathway. Pathway-level signatures were compared across consensus molecular subtypes (CMS) and examined in relation to oncogenic signaling programs, while individual endocytosis-related genes were evaluated for associations with clinical outcomes in an independent randomized trial cohort. Expression of CME and ESCRT pathways varied by CMS, with the highest expression in CMS4 and the lowest in CMS3. Endocytosis signatures correlated with multiple oncogenic signaling pathways, including MAPK, TGF-β, WNT, PI3K, NOTCH, and angiogenesis, suggesting broad links between endocytic activity and tumor biology. In the randomized phase III CALGB/SWOG 80405 trial, low expression of AP2M1 —a core adaptor in the CME complex—was significantly associated with longer overall survival and progression-free survival in patients treated with anti-EGFR agents, but not in those receiving anti-VEGF agents. These findings suggest that endocytic trafficking may be associated with oncogenic signaling and differential therapeutic benefit in patients with metastatic CRC. The endocytosis pathway reflects biologically relevant heterogeneity in CRC and may help guide therapeutic stratification.
Associations Between Cumulative Head Trauma and Self‐Reported Parkinsonism and Parkinson's Disease in Former Soccer Players
Miner, Annalise E., Kmiecik, Matthew J., Dunckley, Nathaniel, Adler, Charles H., Driver‐Dunckley, Erika , Nowinski, Christopher J. , Gottesman, Joshua , Tripodis, Yorghos, Stern, Robert A., McKee, Ann C., Stein, Thor D., Alosco, Michael L., Driver-Dunckley, Erika D., Miner, Annalise E., Kmiecik, Matthew J. , Namburi, Niharika , Dunckley, Nathaniel, Adler, Charles H. , Tripodis, Yorghos , McKee, Ann C. , Stein, Thor D. , Mez, Jesse , Briggs, Farren , Alosco, Michael L.

Mayo Clinic

Movement Disorders | June 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/mds.70380 | PMID 42252813 Get It

Abstract Background Cumulative head trauma, encompassing repetitive head impacts (RHI) and traumatic brain injury (TBI), has been associated with later‐life neurodegenerative disease. Studies on parkinsonism/Parkinson's disease (PD) have evaluated RHI and TBI in isolation, yielding mixed results. Cumulative head trauma may better predict PD risk. Objective To examine independent and cumulative effects of RHI through soccer participation and TBI history on PD diagnosis and age at diagnosis. Methods We used a cross‐sectional cohort design with data from the Fox Insight study. Participants completed self‐report questionnaires on PD diagnosis, TBI (no TBI, TBI with loss of consciousness [LOC], TBI without LOC), and sport participation. Multivariable logistic regressions examined the effects of soccer, TBI group, and their interaction on PD diagnosis. Cox proportional hazards examined associations with time to PD diagnosis. Covariates included age, sex, race, education, income, body mass index, heart disease/diabetes, and family PD history. Results Among 1231 participants (mean[SD] age = 66.12[10.60]), 278 played soccer (953 non–contact and collision sport [CCS] athletes). Participants reported no TBI (390[33%]), TBI without LOC (495[43%]), or TBI with LOC (258[23%]). Overall, 768(62%) reported a PD diagnosis (mean[SD] age at diagnosis = 59.02[9.86]). A significant soccer × TBI interaction indicated that soccer players with TBI with LOC had 2.6× higher odds of PD compared to non‐CCS athletes without TBI (OR [95% CI] = 2.600[1.085–6.305], P = 0.033). Former soccer players with TBI with LOC had a 15.6% higher hazard of early PD diagnosis (HR = 1.469, P = 0.027) compared to non‐CCS athletes with no TBI. Conclusion Cumulative head trauma (RHI + TBI) increased PD risk and lowered age at onset. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Design and preliminary report of a randomized phase IIb clinical trial of multitargeted recombinant adenovirus 5 vaccines against CEA, MUC1, and brachyury (Tri-Ad5) and the IL-15 receptor superagonist nogapendekin alfa inbakicept in Lynch syndrome (TRIAD5-
Bansal, Ajay, Stoffel, Elena M., Lim, Ramona , Burke, Carol, Hall, Michael J., Singh, Aparajita , Boardman, Lisa A., Samadder, Niloy Jewel, Ballestar, Veroushka, Muller, Charles, Scott, Aaron J. , Xu, Yanfei , Eickhoff, Jens, Meredith, Hyun, Aquila, Lanni , Szabó, Éva , Della’Zanna, Gary , Bengtson, Lisa, Schlom, Jeffrey, Donahue, Renee N., Horn, Lucas A., Palena, Claudia, Gulley, James L., Samaddar, Sohini, Moore, Dennis F., Sharma, Parth, Madan, Rashna , Hurley, Karen, Soon‐Shiong, Patrick , Gabitzsch, Elizabeth, Sender, Lennie, Brenner, Dean, Schuetze, Scott, Djuric, Zora, Barroilhet, L. E., Thompson, Patricia, Bauman, Julie, Khan, Seema, Vilar, Eduardo, Szabo, Eva , Stoffel, Elena M. , Stanich, Peter P. , Patel, Swati , Burke, Carol A. , Hall, Michael J. , Muller, Charles , Benante, Kelly A. , Eickhoff, Jens C. , Zaborek, Jen , Umar, Asad , Richmond, Ellen S. , Schlom, Jeffrey , Donahue, Renee Nicole , Toney, Nicole J. , Palena, Claudia , Gulley, James L , Moore, Dennis F., Djurić, Zora , Barroilhet, Lisa , Vilar, Eduardo

Mayo Clinic

Frontiers in Immunology | May 19, 2026 | Volume: 17 | Issue: No issue available | Pages: No page available

10.3389/fimmu.2026.1809281 | PMID 42238576 Get It

Introduction Lynch syndrome (LS) is a hereditary cancer syndrome that increases risk for colorectal and other cancers. We hypothesize that vaccines against tumor-associated antigens CEA, MUC1, and brachyury, simultaneously delivered in an adenovirus serotype-5 vector (Tri-Ad5) combined with the immune-enhancing IL-15 receptor superagonist nogapendekin-alfa-inbakicept (NAI) will reduce the incidence of colorectal neoplasms in LS carriers. Methods In this ongoing phase IIB double-blind placebo-controlled trial, two open-label safety phases (SPs) assessed safety of Tri-Ad5 alone (SP1, n=10) and with added NAI (SP2, n=10). A randomized controlled trial (RCT) follows the SPs. After baseline colonoscopy, vaccine dosing occurs at weeks 0, 4 and 8; Tri-Ad5 alone in SP1 and Tri-Ad5 plus NAI in SP2, with identical boosters at Week 52. The RCT phase participants (n=138) were randomized to receive Tri-Ad5 plus NAI or placebo. All participants complete colonoscopy at Weeks 52 and 104 for assessment of the primary endpoint: cumulative colorectal neoplasm incidence. Secondary endpoints include safety, tolerability, and immunogenicity. Results All 20 SP participants (median age 57.5 (range 42–75), 70% female, 15% minority) received all prime and booster series. SP1 participants reported 139 adverse events (AEs) and SP2 participants reported 178. AEs were predominantly grade 1; no treatment-related serious adverse events (SAEs) occurred. The most common treatment-related AEs were reactogenic events including grade 3 rash (without skin necrosis or breakdown) at NAI injection site (100% of SP2 participants). The RCT phase (n=138) recently completed accrual. Discussion In LS carriers without active cancer, the combination of Tri-Ad5 + NAI was well-tolerated; the RCT phase is ongoing. Clinical Trial Registration https://clinicaltrials.gov/study/ , identifier NCT05419011.
Anatomical Variants of the Shoulder: Pitfalls and Clinical Significance
Haug, Logan P. , Fox, Michael G. , Shah, Amar S, Shah, Amar , Shrestha, Roman, Pollock, Jordan Riley

Mayo Clinic

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren | April 15, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/a-2805-0742 | PMID 41985469 Get It

Abstract Variants of the shoulder are commonly encountered and may occasionally be confused with pathological conditions. Our goal is to provide an overview of common normal variants of the shoulder’s anatomical structures as well as any associated clinical or surgical relevance. Following a literature search of common variants of the shoulder and supporting structures, this review provides a summary of variants related to the scapular body, acromion, glenoid, coracoid, labrum, long head biceps tendon, glenohumeral ligamentous complex, and rotator cuff. The shoulder is composed of the glenohumeral, acromioclavicular, sternoclavicular, and scapulothoracic joints and their associated osseous, ligamentous, cartilaginous, and musculotendinous stabilizers. Anatomic variants about the shoulder, especially in the adolescent and young adult populations, are frequently encountered. An awareness of associated pathological conditions and an understanding of when variants might be clinically significant is important in interpreting radiological exams.
Imaging Findings of Chronic Coccidioidomycosis Septic Arthritis and Osteomyelitis of the Shoulder Joint
Sams, Amanda L., Sill, Andrew , Wyse, Aaron J., Fox, Michael G. , Wyse, Aaron

Mayo Clinic

Roentgen Ray Review | March 19, 2026 | Volume: 2 | Issue: 2 | Pages: No page available

10.2214/r3j.25.01092 Get It

A precise atlas of the human subcortex
Friedrich, Helen, Sahin, Ilkem Aysu , Alho, Eduardo Joaquim Lopes , Holanda, Vanessa Milanese, Brammerloh, Malte , Matthies, Cordula , Volkmann, Jens, Meyer, Garance M. , Kirilina, E. ; https://orcid.org/0000-0003-1304-4363, Pijar, Julianna , Garimella, Arun , Fox, Michael D, Friedrich, Maximilian, Edlow, Brian L., Neudorfer, Clemens, Horn, Andreas, Li, Ningfei , Edlow, Brian L , Horn, Andreas , Rajamani, Nanditha , Oxenford, Simón , Mustin, Maike, Zvarova, Patricia , Krüger, Lara, Demann, Richard, Goede, Lukas L. , Kirilina, Evgeniya P. , Volkmann, Jens , Horisawa, Shiro , Howard, Calvin, Fox, Michael , Friedrich, Maximilian, Bochtler, Anja, Edlow, Brian L. , Neudorfer, Clemens , Horn, Andreas

Mayo Clinic

No container title available | February 15, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.02.13.705755 | PMID 41726876 Get It

Abstract Clinical interventions and neuroimaging in the subcortex require anatomical definitions that exceed the resolution and anatomical detail of currently available deformable brain atlases. Here, we introduce a high-resolution human brain atlas comprising 95 manually segmented grey and white matter structures as well as 82 white matter tracts compiled from a multitude of resources including ex-vivo MRI, histology, fibre dissections, and neuroanatomy textbooks. The atlas is defined at an isotropic resolution of 100 μm and can be precisely deformed to individual subject brain anatomy. By providing precise definitions of both grey and white matter structures within and around the basal ganglia, thalamus, subthalamus, midbrain and cerebellum, the atlas provides a foundational resource for stereotactic surgery and subcortical brain imaging research, as well as for development of next-generation neuromodulation strategies.
0.05% Chlorhexidine gluconate is not associated with infection in antibiotic impregnated inflatable penile prosthesis surgery: results from a large multi-institutional collaborative
Ivan, Samuel , Chawareb, Elia Abou , Hammad, Muhammed, Lesgart, Michael , Baird, Bryce , Bajic, Petar , Barham, David W. , Bernie, Helen Levey, Chung, Paul, Cowan, Ketch , Dominick, Zayda, Good, J , Hsieh, Michael H. , Im, Brian H. , Kadakia, Y , Kohler, T, Lentz, Aaron , Mass-Lindenbaum, Marcelo , Morey, Allen F, Perito, Paul , Sadeghi‐Nejad, Hossein , Schammel, Joshua , Shridharani, Anand, Sarantos, Nicklas, Suarez‐Sarmiento, Alfredo, Warner, J Nicholas, Welliver, Charles E, Ziegelmann, M, Yafi, Faysal A, Gross, Martin , Simhan, Jay, Hammad, Muhammed , Ivan, Samuel J , Abou Chawareb, Elia , Helo, Sevann , Hammad, Muhammed A M , Bernie, Helen L. , Bole, Raevti , Kadakia, Yash , Morey, Allen F. , Nguyen, Vi , Pereira, Thairo Alves , Sarantos, Nicklas , Welliver, Charles , Ziegelmann, M, Yafi, Faysal A. , Simhan, Jay

Mayo Clinic

The Journal of Sexual Medicine | December 12, 2025 | Volume: 23 | Issue: 1 | Pages: No page available

10.1093/jsxmed/qdaf368 | PMID 41489194 Get It

Abstract Background 0.05% Chlorhexidine gluconate (CHG) is now commonly used as an antiseptic irrigation for inflatable penile prosthesis (IPP) surgery. Limited in vitro data suggest compatibility of 0.05% CHG with antibiotic impregnated IPP devices; however, very little clinical research exists to guide use of 0.05% CHG in this population. Aim Assess the relationship of 0.05% CHG and antibiotic impregnated IPP infection in a large multi-institutional cohort. Methods We retrospectively reviewed a multi-institutional cohort of patients who underwent antibiotic impregnated IPP implantation. We identified cases using intraoperative 0.05% CHG and an equal number of consecutive control cases without 0.05% CHG use from each center for comparison. The primary outcome was IPP infection requiring explantation. Patient demographics and surgical variables were analyzed using chi-square tests and multivariable logistic regression to identify variables associated with infection. Outcomes The primary outcome was IPP infection requiring device explanation. Results Among 14 participating institutions, 761 cases using an antibiotic impregnated IPP were analyzed. Of these, 348 (45.7%) had 0.05% CHG used during the case. Median follow-up was 4 months (interquartile range 1-12) for the 0.05% CHG group and 8 months (interquartile range 2-21) for the control group. Intraoperative 0.05% CHG utilization was not associated with antibiotic impregnated IPP infection rate (1.9% vs. 2.0%, P = .9). On multivariable analysis, prior IPP infection (OR 6.32, 95% CI 1.32-30.2, P = .021) and prior priapism (OR 10.01, 95% CI 1.18-89.7, P = .039) were associated with increased infection risk. Clinical implications The use of 0.05% CHG irrigation with antibiotic impregnated IPPs was associated with similar infection rates compared to antibiotic irrigation. Strengths and limitations Limitations include the use of a historical comparator cohort which may introduce unknown confounders, practice variation between multiple sites, shorter follow-up in the 0.05% CHG cohort, and the low incidence of IPP infection which may limit statistical power despite a large sample. The major strengths include the large, multi-institutional cohort, and the use of consecutive patients to minimize selection bias. Conclusion 0.05% CHG utilization was not associated with infection rates in antibiotic impregnated IPPs.